There were 1,059 press releases posted in the last 24 hours and 179,014 in the last 365 days.

VetStem Biopharma Shares the Success Story of Bailee who was Treated with VetStem Cell Therapy by Dr. Susan Burkhart


Bailee, a Springer Spaniel, was treated for Intervertebral Disc Disease with VetStem Cell Therapy by Dr. Susan Burkhart of Animal Medical Center of Ontario.

He was once again smiling, and out of pain.”
— Bailee's Owner

POWAY, CALIFORNIA, US, July 28, 2020 / -- Bailee, an English Springer Spaniel, was approximately fourteen years old when he injured his neck. He jumped off a deck that was about four feet off the ground and yelped in pain. His owner took him to a veterinarian who prescribed pain medications. Unfortunately for Bailee, the medications made him very lethargic and did not help his pain. Bailee was diagnosed with Intervertebral Disc Disease (IVDD).

IVDD is a condition in which one or several intervertebral discs in the spine bulge, resulting in pressure on the spinal cord. This pressure may result in extreme pain and possibly loss of limb function. IVDD can be a result of chronic disc degeneration or from an acute injury. Conservative treatment with pain medications and anti-inflammatories may help patients who have a gradual onset of symptoms or whose symptoms are mild. In severe cases or when there are repeated episodes, surgery may be recommended.

Due to the severity of his symptoms and his lack of response to conservative management with pain medications, Bailee’s owner took him to a second veterinarian who recommended treatment with VetStem Cell Therapy. Dr. Susan Burkhart of Animal Medical Center of Ontario collected fat from Bailee’s side in a minimally invasive anesthetic procedure. The fat was aseptically packaged and shipped to the VetStem laboratory in Poway, California. Once received, VetStem lab technicians processed the fat to extract and concentrate Bailee’s stem and regenerative cells. One injectable stem cell dose was shipped back to Dr. Burkhart and Bailee received an intravenous injection of his own stem cells approximately 48 hours after the initial fat collection.

Within one week after his stem cell injection, Bailee’s owner reported that she noticed a huge difference. She stated, “He was once again smiling, and out of pain. It has been 2.5 years since then, and Bailee is one happy pup, once again, and able to live many more years pain free. I am so grateful and would do again for any of my pets.”

Stem cells are regenerative cells that can differentiate into many tissue types, reduce pain and inflammation, help to restore range of motion, and stimulate regeneration of tendon, ligament and joint tissues. VetStem Cell Therapy is most commonly used for the treatment of orthopedic conditions such as osteoarthritis and injured tendons or ligaments. Bailee’s case was handled under VetStem’s clinical research department, as there is limited data to support the use of stem cell therapy for the treatment of IVDD. Since this condition develops for different reasons, the stem cell protocol and outcome can vary for each dog. Any inquiries regarding treatment of similar conditions or other non-standard indications should be directed to VetStem personnel.

About Dr. Susan Burkhart, DVM
Dr. Burkhart received her DVM from Ohio State University College of Veterinary Medicine in 1990. She has practiced small and exotic animal medicine and has also served as Assistant Professor of Small Animal Medicine at OSU. She has been utilizing VetStem Cell Therapy since 2008.

About VetStem Biopharma, Inc.
VetStem Biopharma is a veterinarian-led Company that was formed in 2002 to bring regenerative medicine to the profession. This privately held biopharmaceutical enterprise, based near San Diego, California, currently offers veterinarians an autologous stem cell processing service (from patients’ own fat tissue) among other regenerative modalities. With a unique expertise acquired over the past 15 years and 17,000 treatments by veterinarians for joint, tendon or ligament issues, VetStem has made regenerative medicine applications a therapeutic reality. The VetStem team is focused on developing new clinically practical and affordable veterinary solutions that leverage the natural restorative abilities present in all living creatures. In addition to its own portfolio of patents, VetStem holds exclusive global veterinary licenses to a large portfolio of issued patents in the field of regenerative medicine.

Kristi Hauta
VetStem Biopharma
+1 858-748-2004
email us here